The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • FLINN IW
    • GASZTONYI Z
    • OFFNER F
    • LUNIN S
    • BOSCH F
    • DAVIDS MS
    • LAMANNA N
    • JAEGER U
    • GHIA P
    • CYMBALISTA F
    • PORTELL CA
    • HILLMEN P
    • SKARBNIK AP
    • CASHEN AF
    • WEAVER DT
    • KELLY VM
    • TURNBULL B
    • STILGENBAUER S
    • MONTILLO M
    • NAGY Z
    • ILLES A
    • ETIENNE G
    • DELGADO J
    • KUSS BJ
    • A/PROF Constantine Tam

Published in

  • Blood

Time

Date/time value

  • 2018

Identity

Digital Object Identifier (DOI)

  • 10.1182/blood-2018-05-850461

Additional Document Info

Parent Title

  • BLOOD

Volume

  • 132

Issue

  • 23

Publisher

  • American Society of Hematology